Argenx
ARGX
#523
Rank
HK$310.17 B
Marketcap
HK$5,105
Share price
-1.58%
Change (1 day)
71.61%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - Total debt

Total debt on the balance sheet as of June 2024 : HK$0.26 Billion

According to Argenx 's latest financial reports the company's total debt is HK$0.26 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Argenx - Total debt on balance sheet (from 2017 to 2020)

Total debt by year

Year Total debt Change
2022-12-31HK$97.08 M8.6%
2021-12-31HK$89.39 M-2.91%
2020-12-31HK$92.08 M44.2%
2019-12-31HK$63.85 M
2018-12-31N/A
2017-12-31N/A
2013-12-31N/A-100%
2012-12-31HK$22.94 M3.72%
2011-12-31HK$22.11 M